All Stories

  1. Emerging therapies against infections with Pseudomonas aeruginosa
  2. Low transmission risk of Pseudomonas aeruginosa in a bronchiectasis clinic based on the knowledge of bacterial population biology
  3. Long-Term Microevolution of Pseudomonas aeruginosa Differs between Mildly and Severely Affected Cystic Fibrosis Lungs
  4. Effects of Lumacaftor–Ivacaftor Therapy on Cystic Fibrosis Transmembrane Conductance Regulator Function in Phe508del Homozygous Patients with Cystic Fibrosis
  5. Recent advances in understanding Pseudomonas aeruginosa as a pathogen
  6. Adherence ofPseudomonas aeruginosato cystic fibrosis buccal epithelial cells
  7. Molecular Epidemiology of Mutations in Antimicrobial Resistance Loci of Pseudomonas aeruginosa Isolates from Airways of Cystic Fibrosis Patients
  8. The cystic fibrosis lower airways microbial metagenome
  9. Therapie der Mukoviszidose mit CFTR-Modulatoren
  10. Nasal potential difference of carriers of the W493R ENaC variant with non-cystic fibrosis bronchiectasis: TABLE 1
  11. Gerd Döring (1948-2013)